Clinical Trial Update: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and potential early efficacy of NST-628 oral tablets in adults with solid tumors is currently recruiting, including tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Melanoma
• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• NST-628

Snippet

Sponsor: Nested Therapeutics, Inc | Conditions: Oncology, MEK Mutation | Phase 1 | Status: RECRUITING